Table 3.
Percentage of responders in the intention-to-treat (ITT) population
| ITT with LOCF population | TRZ30 (n = 43) | TRZ60 (n = 50) | PLB (n = 48) | p value |
|---|---|---|---|---|
| Responder, n (%) | 27 (62.8) | 27 (54.0) | 22 (45.8) | 0.428a |
| Non-responder, n (%) | 16 (37.2) | 23 (46.0) | 26 (54.2) |
All investigational groups also received gabapentin as background therapy
LOCF last observation carried forward, PLB placebo, TRZ trazodone
aVariables were compared by the Cochran–Mantel–Haenszel test